The choleretic effects of inchinkoto (ICKT), a hepatoprotective herbal medicine, are variable among patients. This study sought to investigate the correlation between the choleretic effects of ICKT and the intestinal microenvironment in patients with biliary obstruction.
INTRODUCTION
H ERBAL MEDICINE CONSISTS of complex mixtures of organic products that are mainly derived from plants, including flowers, leaves, roots, and seeds. Its effectiveness for various human diseases has been tested through long-term empirical trials in Eastern countries, and herbal medicine has occupied an important position as a complement to or replacement of Western medicine in Japan, China, and other Asian countries. However, because of the absence of convincing scientific evidence, the mechanisms of pharmaceutical actions of herbal medicines are largely unknown.
Inchinkoto (ICKT) is one of the most popular hepatoprotective herbal medicines used in Japan. The biological properties of ICKT and its major active constituents have been studied in numerous experiments involving cultured cells and laboratory animals. [1] [2] [3] [4] These reports showed the anticholestatic, 2, 3 anti-apoptotic, 1, 4 anti-inflammatory, 5 and antifibrotic effects 6 of ICKT. Additionally, there are several clinical reports showing ICKT is beneficial as a hepatoprotective agent.
Inchinkoto is composed of three crude medicinal plants: Artemisia capillaris Flos, Gardeniae Fructus, and Rhei Rhizoma. The major constituent of Artemisia capillaris Flos is dimethylesculetin, that of Gardeniae Fructus is geniposide, and that of Rhei Rhizoma is sennoside A. Of these, geniposide, a main iridoid glucoside component, is the most abundant compound in ICKT. After oral intake, geniposide is converted to genipin by the intestinal bacteria through the action of bacterial β-glucosidase. 7, 8 Genipin is then absorbed from the intestinal mucosa and is transported to the liver through the portal circulation. In a previous experimental study using mice, oral chloramphenicol, which decreases the conversion from geniposide to genipin by damaging intestinal bacteria, 9 offsets the pharmacological effects of ICKT.
1 Additionally, our previous human trial results showed that the choleretic effects of ICKT in patients undergoing biliary drainage were variable. 10 Because the intestinal microenvironment is different in each patient, these observations imply the importance of the intestinal microenvironment for the pharmacological action of ICKT.
In the current study, we hypothesized that the intestinal microenvironment has a significant impact on the choleretic action of ICKT, probably by affecting the metabolism of geniposide to genipin and the absorbance of genipin into the circulation. We gave ICKT to patients undergoing external biliary drainage for an extrahepatic biliary obstruction and measured the changes in the biliary concentrations of total bilirubin and bile acids. We also sampled feces and determined their fecal profile, including concentrations of representative fecal bacteria and fecal organic acids, and tested whether there is any correlation between the choleretic effect of ICKT and the fecal profile.
METHODS

Patients
From August 2014 to March 2016, patients with a biliary obstruction who underwent external biliary drainage either by endoscopic nasal biliary drainage (ENBD) or percutaneous transhepatic biliary drainage (PTBD) were enrolled in this study. The study protocol is shown in Figure 1 . Before starting ICKT treatment, patients waited at least 3 days after biliary drainage until the daily amount of drained bile became constant. Drained bile was replaced either by oral intake or through a nasogastric tube in all patients. Patients taking other choleretic agent, such as ursodeoxycholic acid, were excluded. Informed consent was obtained from all patients. The study protocol was approved by the Nagoya University Ethics Committee and registered in the University Hospital Medical Information Network (registration nos. UMIN000013250 and UMIN000020274).
Treatment with ICKT
When the daily amount of drained bile stabilized, ICKT (TJ-135; Tsumura & Co., Tokyo, Japan) was given orally three times per day at a daily dose of 7.5 g (2.5 g in each packet) (Fig. 1 ).
Bile sample analysis
Bile samples were collected from the biliary decompression tube (ENBD or PTBD) before ICKT treatment, 3 h and 24 h after the first intake of ICKT (Fig. 1) . The concentrations of total bile acid, total bilirubin, and direct bilirubin in the bile samples were measured using standard laboratory methods.
QUANTIFICATION OF SERUM GENIPIN
Sample preparation B LOOD SAMPLES WERE collected at the same time points of bile sampling (Fig. 1) . For quantification of genipin, 50 μL plasma was mixed with 50 μL water and acetonitrile (4:1, v/v), 10 μL internal standard solution (100 ng/mL niflumic acid), and 300 μL acetonitrile. The mixture was centrifuged at 1800 g at 4°C for 15 min. The supernatant was collected in a test tube and dried at 40°C in a dry bath under a stream of nitrogen gas. The residue was redissolved with 100 μL water and acetonitrile (9:1, v/v). An aliquot (20 μL) of each sample was injected onto the analytical column.
Analysis conditions
The binary gradient elution was fulfilled as follows: (i) start at 10% B in minutes 0-2; (ii) linear gradient from 10% B to 35% B in minutes 2-8; and (iii) maintained at 35% B from minutes 8 to 12. The mass spectrometer was operated in negative-ion mode. The pressures of ion source gas 1, ion source gas 2, curtain gas, and collision-activated dissociation gas were 70, 80, and 40 psi, and level 7, respectively. The optimized TurboIonSpray (AB Sciex, Framingam, MA, USA) voltage and temperature were set at À4500 V and 600°C, respectively. Multiple reaction monitoring transitions were set at m/z 225.0 to 122.9 for genipin.
Fecal bacteriologic examination Sampling of feces
Approximately 1 g feces was collected in a test tube that contained 2 mL RNAlater (Ambion, Austin, TX, USA) for the determination of the bacterial count. The bacteria were counted using the bacterium-specific rRNA-targeted reverse transcription-quantitative polymerase chain reaction (RT-qPCR) using a Yakult Intestinal Flora-SCAN system (YIF-SCAN; Yakult, Kunitachi-shi, Tokyo, Japan), which is more sensitive than the conventional culture method for detecting bacteria. 11 The second sample was collected into an empty test tube to determine the fecal organic acid concentrations. The samples were held at room temperature for 10 min before storage at À20°C.
Measurement of bacterial counts in feces
The RT-qPCR method used to measure the bacterial counts in feces has been described elsewhere. 12, 13 Briefly, the microbiota composition was analyzed using the Yakult Intestinal Flora-SCAN (YIF-SCAN) version of a 16S rRNA-targeted RT-qPCR system. The number of representative fecal bacteria and bacteria considered pathogenic based on previous studies were counted. 14, 15 Those included obligate anaerobes (Clostridium coccoides group, C. leptum subgroup, Bacteroides fragilis group, Bifidobacterium, Atopobium cluster, Prevotella, C. difficile, and C. perfringens) and facultative anaerobes (Lactobacillus, Enterobacteriaceae, and Enterococcus). Among them, C. difficile, C. perfringens, Enterobacteriaceae, and Enterococcus are considered harmful bacteria because fecal concentrations of these bacteria are increased in pathological conditions.
Measurement of fecal organic acid concentrations
Feces were homogenized in four volumes of 0.15 μmol/L perchloric acid and allowed to stand at 4°C for 12 h. The homogenate was placed in an Eppendorf tube and centrifuged at 20 400 g at 4°C for 10 min. Then, the resulting supernatant was passed through a filter with a pore size of 0.45 μm (Millipore Japan, Tokyo, Japan). The sample was analyzed for organic acids by high-performance liquid chromatography as previously described 16 using a Waters HPLC system (432 Conductivity Detector; Waters, Milford, MA, USA) equipped with two columns (Shodex Rspack KC-811; Showa Denko, Tokyo, Japan). Concentrations of representative organic acids, such as acetic acid, propionic acid, butyric acid, and lactic acid were calculated using external standards and were expressed as micromoles per gram of wet feces.
Statistical analysis
Statistical analysis was carried out using JMP version 11 for Windows (SAS Institute, Cary, NC, USA). The results are presented as median (interquartile range). The Wilcoxon signed-rank test was used to compare the two groups, and Spearman's rank correlation was used for correlation analysis. P-values of less than 0.05 were considered to indicate a significant difference.
RESULTS
Patient characteristics
S AMPLES FROM 37 patients were collected and analyzed. Most of the patients were diagnosed with biliary tract carcinomas, including perihilar cholangiocarcinoma, distal cholangiocarcinoma, and gallbladder carcinoma (Table 1 ). In most of the patients, biliary drainage was undertaken using ENBD. Patients' abdominal symptoms, number of bowel movements, and fecal hardness were not significantly altered by treatment with ICKT.
Serum concentrations of genipin after ICKT
Although no genipin was detected in the serum before ICKT treatment in any patient, the serum concentration of genipin increased 3 h and 24 h after the first intake of ICKT (Fig. 2a) . Although the median concentration of genipin was higher 3 h after ICKT treatment, genipin was still detected 24 h after the first intake of ICKT. Moreover, there was a positive correlation between the genipin (Fig. 2b) .
Correlation between serum genipin concentrations and choleretic effects of ICKT Serum concentrations of genipin 3 h after the first intake of ICKT showed a positive correlation with the percent changes in the biliary concentrations of bile acid, total bilirubin, and direct bilirubin, indicating that genipin might contribute, at least partly, to the choleretic effects of ICKT (Fig. 3) .
Correlation between fecal concentrations of studied bacteria and fecal organic acid concentrations
The fecal concentrations of short chain fatty acids showed positive correlations with representative fecal obligate anaerobes such as the C. coccoides group, C. leptum subgroup, Bacteroides fragilis group, Bifidobacterium, and the Atopobium cluster (Fig. 4a-c) . In contrast, there was a trend of negative correlation between the fecal concentration of lactic acid and representative fecal obligate anaerobes (Fig. 4d) . Interestingly, the fecal concentration of lactic acid was positively correlated with the concentration of harmful bacteria such as Enterococcus.
Correlation between serum genipin concentration and fecal profile
Oral intake of ICKT did not change. Based on our hypothesis that the fecal profile has some association with the metabolism of geniposide to genipin and the absorbance of genipin from the intestine, we next examined the correlation between serum genipin concentration and the fecal concentrations of the studied bacteria and organic acids 3 h after the first intake of ICKT. Overall, the serum genipin concentration showed a positive correlation with the fecal concentrations of the representative obligate anaerobes (Fig. 5a) . In sharp contrast, the fecal concentrations of so-called harmful bacteria, such as C. difficile, C. perfringens, Enterobacteriaceae, and Enterococcus, showed a negative correlation with the serum concentration of genipin. Similarly, genipin concentration 3 h after the first intake of ICKT showed a positive correlation with the fecal concentration of propionic acid and butyric acid and a negative correlation with the fecal concentration of lactic acid (Fig. 5b) .
DISCUSSION
I
NCHINKOTO IS ONE of the most commonly used hepatoprotective herbal medicines in Japan. Although previous studies supported the clinical utility of ICKT in patients with various liver diseases, especially for those with a biliary obstruction, there was considerable variation in the therapeutic responses to ICKT. In our previous study, we reported increased concentrations of biliary bile acid and total bilirubin in approximately 70% of patients with biliary drainage following oral treatment with ICKT. 10 However, in the remaining 30% of patients, ICKT did not exert a choleretic effect. We hypothesized that these variable responses to ICKT in each patient are associated with the patients' specific fecal profile, as the condition of Figure 4 Correlations between the fecal concentrations of organic acids and the fecal concentrations of the studied bacteria in patients with biliary obstruction treated with inchinkoto. The x-axis indicates the rho value (correlation coefficient) by Spearman's rank correlation analysis. *P < 0.05. Figure 5 Correlations between serum concentrations of genipin (3 h after first intake of inchinkoto [ICKT] ) and the fecal concentrations of the studied bacteria (a) and organic acids (b) in patients with biliary obstruction. The x-axis indicates the rho value (correlation coefficient) by Spearman's rank correlation analysis. *P < 0.05. the intestinal microenvironment may have some impact on the metabolism and absorption of the ingredients in ICKT.
The results of the fecal analysis showed that the fecal concentrations of short chain fatty acids such as acetic acid, propionic acid, and butyric acid were positively correlated with the fecal concentrations of major obligate anaerobes such as the C. coccoides group, C. leptum subgroup, Bacteroides fragilis group, Bifidobacterium, and the Atopobium cluster. These bacteria predominate in a normal intestinal microenvironment. In other words, if these bacteria are predominant in feces, the intestinal microenvironment is healthy. Interestingly, the fecal concentration of lactic acid was negatively correlated with the concentrations of these bacteria and positively correlated with the concentration of Enterococcus, one of the representative harmful bacteria in feces. In normal intestinal microflora, lactic acid is produced by lactic acid-producing bacteria, but the lactic acid produced is quickly metabolized into short chain fatty acids by normal intestinal microflora in a healthy intestinal microenvironment. 17, 18 When normal intestinal bacteria decrease, and harmful bacteria increase in feces, this metabolism is inhibited, and fecal lactic acid accumulates. Such a fecal condition indicates an unhealthy intestinal microenvironment. 19, 20 In fact, we recently reported that patients with a high concentration of lactic acid and low concentration of short chain fatty acids are more susceptible to bacterial translocation and postoperative infectious complications after highly invasive surgery. 21 Geniposide is one of the major ingredients of ICKT. After oral intake of ICKT, geniposide is metabolized to genipin by the enzyme activity of β-glucosidase. 7, 8 Many intestinal bacteria, especially obligate anaerobes, have been shown to have β-glucosidase enzyme activity. 7, 8, 22 Because genipin has been shown to exert choleretic effects in several animal models, 2, 3 we measured the serum genipin concentration following oral intake of ICKT and investigated its association with the intestinal microenvironment. The serum genipin concentration clearly increased after oral intake of ICKT and showed some positive correlations with the choleretic effects of ICKT, as indicated by the increased biliary concentrations of bile acid, total bilirubin, and direct bilirubin. These results indicated that the choleretic effects of ICKT are at least partly associated with the serum concentration of genipin. Moreover, the serum genipin concentration 3 h after oral intake of ICKT showed a positive correlation with the fecal concentrations of major obligate anaerobes, whereas it showed a negative correlation with the concentration of so-called harmful bacteria. Moreover, the serum genipin concentration also showed a positive correlation with the fecal concentrations of propionic acid and butyric acid (short chain fatty acids), whereas it showed a negative correlation with the concentration of lactic acid. Together, these results implied that the metabolism of geniposide to genipin and its absorption into the bloodstream may be suppressed in an unhealthy intestinal microenvironment with high fecal concentrations of harmful bacteria and lactic acid. In other words, it is important to maintain a healthy intestinal microenvironment to efficiently increase the serum genipin concentration following intake of ICKT. This finding raises the question of how to maintain a healthy intestinal microenvironment in order to maximize the effect of ICKT. Synbiotic treatment might improve the intestinal microenvironment because it has been shown to decrease harmful bacteria and increase short chain fatty acids in feces in several clinical studies. 23, 24 The efficacy of combined use of synbiotics and ICKT should be investigated in future studies.
There are several limitations to this study. The timing of the fecal sampling was variable among patients because the sampling occurred following natural bowel movements. The fecal profile may be influenced by the timing of food intake, the timing of bile replacement, or ICKT intake, and these factors should be standardized in a future study. It may be interesting to investigate the changes in intestinal microenvironment in response to the ICKT either by the direct effects of ICKT components on the intestinal microbiota or indirect effects by increased biliary flow into the intestine induced by ICKT. Although we found some associations between the serum genipin concentration and fecal profile as well as choleretic effects of ICKT, these associations were generally weak according to the rho value (correlation coefficient) by Spearman's rank correlation analysis. Therefore, the choleretic effects of ICKT might not be explained by the serum genipin concentration alone. The choleretic effect in response to ICKT intake has been shown to be associated with increased multidrug resistance-associated protein 2 (MRP2) expression in the liver. 10 The correlation between the expression of MRP2 in the liver and the intestinal microenvironment may be another issue to be addressed in a future study. Because ICKT is composed of multiple crude medicinal plants and contains numerous chemical compounds, the impact of other components on the choleretic effect of ICKT should also be elucidated.
In conclusion, this study showed that the serum concentration of genipin, which has been considered a major active ingredient contributing to the pharmacological effect of ICKT, increased after ICKT intake and showed an association with the fecal microenvironment profile. Moreover, the serum concentration of genipin showed a
